FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W26337488> ?p ?o ?g. }

• W26337488 endingPage "38" @default.
• W26337488 startingPage "33" @default.
• W26337488 abstract "Age is a risk factor and a prognostic parameter in elderly aggressive-histology non-Hodgkin’s lymphoma (NHL) patients. Several adapted chemotherapeutic regimens have recently been designed and tested on elderly patients. Several of these trials have shown that older aggressive-histology NHL patients can benefit from specific and adequate treatment capable of curing a percentage of these patients. Between January 1992 and September 1997, 350 previously untreated aggressive-histology NHL patients greater than 60 years of age were treated with a combination therapy including cyclophosphamide, mitoxantrone, vincristine, etoposide, bleomycin, and prednisone (VNCOP-B). Complete remission (CR) was achieved by 202 (58%) patients and partial remission (PR) by 87 (25%), whereas the remaining 61 (17%) patients were nonresponders. The overall response rate (CR + PR) was 83%. Clinical and hematologic toxicities were modest, because 71% of the patients received granulocyte colony-stimulating factor (G-CSF). The CR rates for the three age groups (60 to 69, 70 to 79, and ≥80 years) were similar: 61%, 59%, and 56%, respectively. At 5 years, the relapse-free survival rate was 65%, the overall survival rate was 49%, and the failure-free survival rate was 33%. In the multivariate analysis, prognostic factors associated with longer survival or longer relapse-free survival turned out to be localized disease stage ( P = .001) and good performance status ( P = .0002). Application of the International Prognostic Factor Index was significantly associated with outcome ( P = .001). These data confirm on a large cohort of patients that the VNCOP-B regimen is effective in inducing good CR and relapse-free survival rates with only moderate toxic effects in elderly aggressive-histology NHL." @default.
• W26337488 created "2016-06-24" @default.
• W26337488 creator A5000093989 @default.
• W26337488 creator A5002237220 @default.
• W26337488 creator A5004888416 @default.
• W26337488 creator A5005495487 @default.
• W26337488 creator A5008077055 @default.
• W26337488 creator A5008693201 @default.
• W26337488 creator A5016603192 @default.
• W26337488 creator A5028241549 @default.
• W26337488 creator A5029563827 @default.
• W26337488 creator A5031937532 @default.
• W26337488 creator A5033359713 @default.
• W26337488 creator A5039006383 @default.
• W26337488 creator A5041681722 @default.
• W26337488 creator A5045339988 @default.
• W26337488 creator A5046307290 @default.
• W26337488 creator A5051820054 @default.
• W26337488 creator A5063235996 @default.
• W26337488 creator A5071128692 @default.
• W26337488 creator A5078922292 @default.
• W26337488 creator A5080224543 @default.
• W26337488 creator A5080710513 @default.
• W26337488 creator A5082960835 @default.
• W26337488 creator A5091882595 @default.
• W26337488 date "1999-07-01" @default.
• W26337488 modified "2023-09-28" @default.
• W26337488 title "Elderly aggressive-histology non-Hodgkin's lymphoma: First-line VNCOP-B regimen experience on 350 patients" @default.
• W26337488 cites W1524381114 @default.
• W26337488 cites W1759514589 @default.
• W26337488 cites W1811037815 @default.
• W26337488 cites W1880028535 @default.
• W26337488 cites W1905145727 @default.
• W26337488 cites W1911079819 @default.
• W26337488 cites W1911120442 @default.
• W26337488 cites W1924320258 @default.
• W26337488 cites W1944772631 @default.
• W26337488 cites W1948967656 @default.
• W26337488 cites W1950143877 @default.
• W26337488 cites W1970938866 @default.
• W26337488 cites W1979300931 @default.
• W26337488 cites W2011581612 @default.
• W26337488 cites W2030074640 @default.
• W26337488 cites W2043725893 @default.
• W26337488 cites W2048158115 @default.
• W26337488 cites W2073151455 @default.
• W26337488 cites W2075679917 @default.
• W26337488 cites W2076668534 @default.
• W26337488 cites W2085853985 @default.
• W26337488 cites W2104755629 @default.
• W26337488 cites W2115023472 @default.
• W26337488 cites W2123678937 @default.
• W26337488 cites W2129214379 @default.
• W26337488 cites W2158027566 @default.
• W26337488 cites W2158429492 @default.
• W26337488 cites W2169771767 @default.
• W26337488 cites W2241705187 @default.
• W26337488 cites W2248522132 @default.
• W26337488 cites W2257556319 @default.
• W26337488 cites W2267575411 @default.
• W26337488 cites W2268975736 @default.
• W26337488 cites W2318772898 @default.
• W26337488 cites W2346039614 @default.
• W26337488 cites W2413147114 @default.
• W26337488 cites W2416501851 @default.
• W26337488 cites W2605539363 @default.
• W26337488 cites W2468177196 @default.
• W26337488 cites W2995133996 @default.
• W26337488 doi "https://doi.org/10.1182/blood.v94.1.33.413k08_33_38" @default.
• W26337488 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10381495" @default.
• W26337488 hasPublicationYear "1999" @default.
• W26337488 type Work @default.
• W26337488 sameAs 26337488 @default.
• W26337488 citedByCount "56" @default.
• W26337488 countsByYear W263374882012 @default.
• W26337488 countsByYear W263374882014 @default.
• W26337488 countsByYear W263374882015 @default.
• W26337488 countsByYear W263374882018 @default.
• W26337488 countsByYear W263374882019 @default.
• W26337488 crossrefType "journal-article" @default.
• W26337488 hasAuthorship W26337488A5000093989 @default.
• W26337488 hasAuthorship W26337488A5002237220 @default.
• W26337488 hasAuthorship W26337488A5004888416 @default.
• W26337488 hasAuthorship W26337488A5005495487 @default.
• W26337488 hasAuthorship W26337488A5008077055 @default.
• W26337488 hasAuthorship W26337488A5008693201 @default.
• W26337488 hasAuthorship W26337488A5016603192 @default.
• W26337488 hasAuthorship W26337488A5028241549 @default.
• W26337488 hasAuthorship W26337488A5029563827 @default.
• W26337488 hasAuthorship W26337488A5031937532 @default.
• W26337488 hasAuthorship W26337488A5033359713 @default.
• W26337488 hasAuthorship W26337488A5039006383 @default.
• W26337488 hasAuthorship W26337488A5041681722 @default.
• W26337488 hasAuthorship W26337488A5045339988 @default.
• W26337488 hasAuthorship W26337488A5046307290 @default.
• W26337488 hasAuthorship W26337488A5051820054 @default.
• W26337488 hasAuthorship W26337488A5063235996 @default.
• W26337488 hasAuthorship W26337488A5071128692 @default.

• next